The following relates to monitoring physiology. It finds particular application to an in-the-ear structure that is inserted in the ear canal to suitably position one or more physiological sensors within the inner ear to capture information indicative of physiological phenomena including blood pressure, respiration, perfusion index, blood oxygen, pulse rate, and body temperature, for example.
Physiological signals have been measured from within the ear. However, there are no multi-parameter physiological measurement devices that non-invasively measure blood pressure from within the ear. Examples of barriers that frustrate such development include the varying size and shape of the human ear canal from person to person, an inability to strategically position sensors within the ear canal to optimally receive physiological signals, and an inability to protect sensing devices from contamination through contact with inner ear tissue while measuring physiological signals.
In one aspect, an in-the-ear physiological measurement device includes a structure formed for insertion into an ear canal. One or more sensors are operatively coupled to a portion of the structure that is positioned in the ear. An inflatable balloon is operatively coupled to the portion of the structure positioned in the ear and inflates to position the one or more sensors proximate to tissue within the ear canal. Once suitably positioned, the one or more sensors sense physiological signals from the surrounding tissue and bone structure.
One advantage includes measuring physiological signals from within the ear.
Another advantage resides in non-invasively measuring blood pressure from within the ear.
Another advantage is continuously measuring non-invasive blood pressure from with the ear.
Another advantage resides in an in-the-ear device that forms to different shaped and sized ear canals.
Another advantage is positioning the sensor within the ear canal to optimally receive physiological signals therefrom.
Another advantage is positioning the sensor within the ear canal with ideal force and pressure to ensure close coupling of sensors with tissue without causing blanching of the tissue.
Another advantage is positioning the sensor within a well perfused physiological site even if the body is experiencing peripheral shutdown due to shock or other conditions.
Another advantage is the prevention of over insertion into the ear.
Another advantage is measuring physiological signals through a sheath that mitigates contamination of the physiological sensors.
Another advantage resides in an in-the-ear physiological signal measuring device that equalizes ear pressure with ambient pressure, especially during balloon inflation and deflation.
Still further advantages will become apparent to those of ordinary skill in the art upon reading and understanding the detailed description of the preferred embodiments.
The end portion of the structure 4 residing in the ear canal includes an annular inflatable balloon 6. The inflatable balloon 6 surrounds the end portion of the structure 4 (as illustrated) or suitable portions thereof. The inflatable balloon 6 ideally supports one or more sensors 8 that are operatively coupled to a surface of the balloon 6 and that measure physiological signals. Suitable sensors include light emitting diodes (LEDs), an infrared (IR) source, light detectors, a pressure transducer, a microphone, and a thermistor, for example. The sensors 8 are strategically positioned on the balloon 6. For example, a light detecting sensor typically is positioned to minimize or prevent absorption of light not indicative of the physiological process under measurement (e.g., light from outside the ear, light emitted from another sensor located on the balloon 6 . . . ). Although depicted as circular in
The inflatable balloon 6 is inflated to position the one or more sensors 8 proximate to appropriate tissue within the ear canal with ideal force and pressure to ensure close coupling of sensors with tissue but without causing decreased perfusion or blanching of the tissue. For adult humans, this includes inflating the balloon 6 to conform to the widely varying ear canal diameters from about 6 mm to about 13 mm. For neonates and small pediatrics, where the ear canal diameter various from about 4 mm in diameter to about 7 mm in diameter, smaller and shorter ITE devices are used. Typically, sensors for measuring blood oxygen are positioned proximate to ear canal tissue that is perfused with arterial blood supplied by branches of the External as well as the Internal Carotid Arteries, thus serving as a well perfused physiological site even if the body is experiencing peripheral shutdown due to shock or other conditions. Such sensors include an energy emitting means (e.g., an LED, an IR source . . . ) and an energy detecting means that detects energy transmission through the vascular tissue. In another example, a temperature sensor (e.g., a thermistor) is also positioned proximate to vascular tissue. In yet another example, sensors for sensing audio signals (e.g., a microphone) indicative of pulse pressure sounds, and/or respirations are suitably positioned in relatively quite regions of the ear canal to mitigate sensing extraneous audio signals (noise).
The inflatable balloon 6 is also used to facilitate non-invasively measuring blood pressure. For a non-invasive blood pressure measurement, the inflatable balloon 6 is inflated until it occludes blood flow in a portion of the ear proximate a blood pressure sensor(s) (e.g., a pressure transducer) operatively connected to the inflatable balloon 6. The pressure in the inflatable balloon 6 is then suitably released to deflate the inflatable balloon 6. A systolic and a diastolic blood pressure are obtained during inflation and/or deflation using an auscultatory approach (e.g., via a microphone operatively connected to the balloon 6) and/or an oscillometric approach (e.g., via optical sensing components attached to the balloon).
A continuous non-invasive blood pressure is measured by obtaining an initial blood pressure measure as describe above and then re-inflating the balloon 6 to a mean pressure. A servo mechanism periodically adjusts balloon pressure to locate a maximum pulse waveform amplitude indicative of mean blood pressure. As long as the derived mean pressure is relatively close to the initial pressure and/or the pulse waveform amplitudes are relatively close, the derived continuous systolic, diastolic, and mean blood pressure are calculated with high accuracy.
The structure 4 includes one or more passageways (as illustrated in
The structure 4 is shown supported in the ear by a (BTE) ear piece 18. The structure 4 can be operatively attached to the ear piece 18. Such attachment can be through a fastening means including a threaded connector, a snap, a set screw, an adhesive, a rivet, etc.
The BTE device 18 can house various electronics that receive physiological signals from the sensors 8 (e.g., via sensor wire extending through the passageways 10 and 12 briefly described above) and transmit the physiological signals to another transceiver (not shown) worn by the subject (e.g., a transceiver worn around the neck or waist) or to a remote device (not shown) such as a monitoring device, a database, a computer, and a graphical display. The BTE device 18 can optionally include a processor (not shown), memory (not shown), and a battery (not shown). The processor is used to control the sensors and electronics, process raw data, and read data from the sensors; the memory is used to store data and/or configuration; and the battery powers the processor, active sensors, and the transceiver.
In the embodiment of
The invention has been described with reference to the preferred embodiments. Modifications and alterations may occur to others upon reading and understanding the preceding detailed description. It is intended that the invention be constructed as including all such modifications and alterations insofar as they come within the scope of the appended claims or the equivalents thereof.
This application claims the benefit of U.S. provisional application Ser. No. 60/695,725 filed Jun. 30, 2005, which is incorporated herein by reference.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/IB2006/051892 | 6/13/2006 | WO | 00 | 11/11/2008 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2007/004083 | 1/11/2007 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
4601294 | Danby et al. | Jul 1986 | A |
5213099 | Tripp | May 1993 | A |
5673692 | Schulze et al. | Oct 1997 | A |
5743261 | Mainiero et al. | Apr 1998 | A |
5853005 | Scanlon | Dec 1998 | A |
6004274 | Nolan et al. | Dec 1999 | A |
6115621 | Chin | Sep 2000 | A |
6172743 | Kley et al. | Jan 2001 | B1 |
6253871 | Aceti | Jul 2001 | B1 |
6283915 | Aceti et al. | Sep 2001 | B1 |
6454718 | Clift | Sep 2002 | B1 |
6556852 | Schulze et al. | Apr 2003 | B1 |
6694180 | Boesen | Feb 2004 | B1 |
6773405 | Fraden et al. | Aug 2004 | B2 |
6850789 | Schweitzer et al. | Feb 2005 | B2 |
20010027335 | Meyerson et al. | Oct 2001 | A1 |
20030092975 | Casscells et al. | May 2003 | A1 |
20040064054 | Clift | Apr 2004 | A1 |
20040078219 | Kaylor et al. | Apr 2004 | A1 |
20040258263 | Saxton et al. | Dec 2004 | A1 |
20050049471 | Aceti | Mar 2005 | A1 |
20050059870 | Aceti | Mar 2005 | A1 |
Number | Date | Country |
---|---|---|
0770349 | May 1997 | EP |
1495783 | Jan 2005 | EP |
1671578 | Jun 2006 | EP |
04256727 | Sep 1992 | JP |
2003290152 | Oct 2003 | JP |
03001180 | Jan 2003 | WO |
2005034742 | Apr 2005 | WO |
Number | Date | Country | |
---|---|---|---|
20090069645 A1 | Mar 2009 | US |
Number | Date | Country | |
---|---|---|---|
60695725 | Jun 2005 | US |